Abstract:
In pharmaceutical company due to inadequate transportation infrastructure supply chain management (SCM) activities account for one-third of the revenue for pharmaceutical companies. A pharmaceutical company's supply chain can save operating costs, increase shareholder value, enhance assets, more effectively satisfy consumer demand, and produce a profit. The difficulties with SCM strategies are identified by applying Goldratt's theory of constraints. Reducing supply chain risk has the potential to have a positive impact on society by lowering product prices for consumers, raising stakeholder satisfaction, and raising living standards.
IIP Series is an online, open-access, peer-reviewed, interdisciplinary Journal. IIP Proceedings provides a comprehensive solution for conferences and edited books that cover research topics across various scientific, technical, and medical disciplines. It aims at disseminating high-level research results and developments to researchers and research groups. It mainly focuses on presenting practical solutions for the current problems in Applied Sciences and Applied Social Sciences.
© 2025